This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by El-Ghar, S. M.G.A. Articles by Prasad, K. Search for Related Content PubMed PubMed Citation Articles by El-Ghar, S. M.G.A. Articles by Prasad, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Kidney Transplantation Hazardous Substances DB MALONALDEHYDE Social Bookmarking                         What's this?

Oxidative Stress in Renal Transplant Patients Who Develop Cardiovascular Disease

Department of Pathology, College of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, Saskatchewan, Canada

Mabood Qureshi, MSc, CLS/C

Department of Pathology, College of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, Saskatchewan, Canada

Ahmed Shoker, MD, FRCPC

Department of Medicine, College of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, Saskatchewan, Canada

Kailash Prasad, MD, PhD, FRCPC, FACC, FICA

Department of Physiology, College of Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, Saskatchewan, Canada, k.prasad{at}usask.ca

Cardiovascular disease limits life expectancy of successful renal transplant patients. Reactive oxygen species have been implicated in the development of atherosclerosis, and high levels could be due to increased production or a decrease in antioxidant reserve. Cardiovascular disease in renal transplant recipients could be due to elevated levels of malondialdehyde (an index of levels of reactive oxygen species) and homocysteine and reduced levels of glutathione. Renal transplant recipients with and without cardiovascular disease were studied along with healthy controls. Serum malondialdehyde, plasma homocysteine, and red blood cell glutathione were measured. The results suggest that levels of serum malondialdehyde and plasma homocysteine were higher in patients with or without cardiovascular disease compared with controls; however, the values were similar in both groups of transplant patients. Glutathione levels in red blood cells were similar in all 3 groups. Renal transplant recipients without cardiovascular disease have high levels of oxidative stress and may develop cardiovascular disease with time.

Key Words: cardiovascular disease • oxidative stress • malondialdehyde

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 11, No. 3, 203-210 (2006)
DOI: 10.1177/1074248406293254


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?